Tempest Therapeutics, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Tempest Therapeutics, Inc. (TPST) had Stockholders' Equity Attributable to Noncontrolling Interest of $668.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2021-05-13
- 2021-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $668.00K.
- 2020-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $668.00K.
- 2020-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $668.00K.
- 2020-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $668.00K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2021-03-31 | $668.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $668.00K 10-Q · filed 2021-05-13 |
| 2020-09-30 | $668.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $668.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $809.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $1.32M 10-K · filed 2021-03-29 |
| 2019-09-30 | $1.75M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $2.06M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $2.17M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.17M 10-K · filed 2020-03-11 |
| 2017-12-31 | $2.17M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |